N-terminal sequences in matrin 3 mediate phase separation into droplet-like structures that recruit TDP43 variants lacking RNA binding elements.


Journal

Laboratory investigation; a journal of technical methods and pathology
ISSN: 1530-0307
Titre abrégé: Lab Invest
Pays: United States
ID NLM: 0376617

Informations de publication

Date de publication:
07 2019
Historique:
received: 15 10 2018
accepted: 09 04 2019
revised: 29 03 2019
pubmed: 26 4 2019
medline: 26 6 2020
entrez: 26 4 2019
Statut: ppublish

Résumé

RNA binding proteins associated with amyotrophic lateral sclerosis (ALS) and muscle myopathy possess sequence elements that are low in complexity, or bear resemblance to yeast prion domains. These sequence elements appear to mediate phase separation into liquid-like membraneless organelles. Using fusion proteins of matrin 3 (MATR3) to yellow fluorescent protein (YFP), we recently observed that deletion of the second RNA recognition motif (RRM2) caused the protein to phase separate and form intranuclear liquid-like droplets. Here, we use fusion constructs of MATR3, TARDBP43 (TDP43) and FUS with YFP or mCherry to examine phase separation and protein colocalization in mouse C2C12 myoblast cells. We observed that the N-terminal 397 amino acids of MATR3 (tagged with a nuclear localization signal and expressed as a fusion protein with YFP) formed droplet-like structures within nuclei. Introduction of the myopathic S85C mutation into NLS-N397 MATR3:YFP, but not ALS mutations F115C or P154S, inhibited droplet formation. Further, we analyzed interactions between variants of MATR3 lacking RRM2 (ΔRRM2) and variants of TDP43 with disabling mutations in its RRM1 domain (deletion or mutation). We observed that MATR3:YFP ΔRRM2 formed droplets that appeared to recruit the TDP43 RRM1 mutants. Further, coexpression of the NLS-397 MATR3:YFP construct with a construct that encodes the prion-like domain of TDBP43 produced intranuclear droplet-like structures containing both proteins. Collectively, our studies show that N-terminal sequences in MATR3 can mediate phase separation into intranuclear droplet-like structures that can recruit TDP43 under conditions of low RNA binding.

Identifiants

pubmed: 31019288
doi: 10.1038/s41374-019-0260-7
pii: S0023-6837(22)02609-5
pmc: PMC6857798
mid: NIHMS1526728
doi:

Substances chimiques

DNA-Binding Proteins 0
MATR3 protein, human 0
Nuclear Matrix-Associated Proteins 0
RNA-Binding Proteins 0
TARDBP protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030-1040

Subventions

Organisme : NIH HHS
ID : S10 OD020026
Pays : United States

Références

Cell. 2015 Aug 27;162(5):1066-77
pubmed: 26317470
Neurobiol Aging. 2015 May;36(5):2005.e1-4
pubmed: 25771394
FEBS Lett. 2015 Jan 2;589(1):15-22
pubmed: 25436423
Nat Neurosci. 2014 May;17(5):664-666
pubmed: 24686783
Sci Rep. 2017 Nov 6;7(1):14529
pubmed: 29109432
Front Neurosci. 2018 May 15;12:326
pubmed: 29867335
Science. 2018 May 25;360(6391):918-921
pubmed: 29650702
Elife. 2018 Jul 17;7:
pubmed: 30015619
Science. 2009 Jun 26;324(5935):1729-32
pubmed: 19460965
J Biol Chem. 1991 May 25;266(15):9893-9
pubmed: 2033075
Cell. 2015 Sep 24;163(1):123-33
pubmed: 26406374
Nucleic Acids Res. 1990 Sep 11;18(17):5322
pubmed: 1698283
Ann Neurol. 2014 Nov;76(5):669-80
pubmed: 25154462
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13318-23
pubmed: 20624952
Int J Mol Sci. 2015 Dec 25;17(1):
pubmed: 26712748
Neurobiol Aging. 2016 Jan;37:209.e17-209.e21
pubmed: 26493020
Trends Biochem Sci. 2018 Feb;43(2):124-135
pubmed: 29289458
Nat Rev Mol Cell Biol. 2013 Dec;14(12):775-86
pubmed: 24220094
Sci Rep. 2018 Mar 6;8(1):4049
pubmed: 29511296
Cell Rep. 2016 Aug 2;16(5):1228-1236
pubmed: 27452472
J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):448-50
pubmed: 25952333
J Biol Chem. 2001 Sep 28;276(39):36337-43
pubmed: 11470789
BMC Syst Biol. 2010 Apr 13;4:44
pubmed: 20388198
Exp Neurol. 2018 Aug;306:222-231
pubmed: 29763601
Biochim Biophys Acta. 2006 May;1759(5):195-207
pubmed: 16814881
PLoS One. 2015 Nov 03;10(11):e0142144
pubmed: 26528920
Brain Res. 2016 Sep 15;1647:9-18
pubmed: 26996412
Curr Opin Struct Biol. 2017 Jun;44:18-30
pubmed: 27838525
Neurobiol Aging. 2017 Jan;49:218.e1-218.e7
pubmed: 28029397
Am J Hum Genet. 2009 Apr;84(4):511-8
pubmed: 19344878
Acta Neuropathol Commun. 2018 Dec 19;6(1):137
pubmed: 30563574
Nature. 2013 Mar 28;495(7442):467-73
pubmed: 23455423
Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):530-1
pubmed: 26199109
Mol Cell. 2015 Oct 15;60(2):189-92
pubmed: 26474062
Front Cell Neurosci. 2015 Oct 23;9:423
pubmed: 26557057
EMBO J. 2015 Mar 4;34(5):653-68
pubmed: 25599992
PLoS One. 2011;6(8):e23882
pubmed: 21858232
J Neurosci. 2015 Dec 9;35(49):16077-93
pubmed: 26658861

Auteurs

M Carolina Gallego-Iradi (MC)

Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Pediatric Stem Cell Transplantation and Regenerative Medicine, School of Medicine, Stanford University, Palo Alto, CA, USA.

Haley Strunk (H)

Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.

Anthony M Crown (AM)

Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Department of Neuroscience, Brown University, Providence, RI, USA.

Rachel Davila (R)

Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.

Hilda Brown (H)

Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.

Edgardo Rodriguez-Lebron (E)

Department of Pharmacology and Therapeutics, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.

David R Borchelt (DR)

Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Gainesville, FL, USA. drb1@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH